4 ms·
Show HN: Last day: New cancer drug candidates
- michaelforrest 8y agogus_massa - in response to your points prior, please see the new figure at the bottom of the experiment.com page. Please also see, for an overview of my (bootstrapped) company, now raising: https://angel.co/company/biophysical-therapeutics https://angel.co/company/biophysical-therapeutics For more technical please see: https://patentscope.wipo.int/search/docs2/pct/WO2019012149/pdf/PpAUZP5Zqw9fmNqL8LoqeF4ZqdXy0OF1dO7_6PtxXGdUgRVmMa2Nc1YlBsuZGzf7oG8RDBP2TOSgzMNAOTWq8zhcFsRB1mtaZr8tTwmjhI0vitaqTSlSzJutGb8eVEWp?docId=id00000045720432&psAuth=z8TolF04c1pSeYym8s1-CHIaLeif5s78ruenoiXZ-ZI https://patentscope.wipo.int/search/docs2/pct/WO2019012149/p...
- gus_massa 8y agoSome relevant parts of https://en.wikipedia.org/wiki/Carboplatin https://en.wikipedia.org/wiki/Carboplatin > It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. This is discussed in the patent, but not in the submission. Add something about it. I don't know which are the current preferred drugs against cancer. The patent takes forever to load. I got more luck with https://patentscope.wipo.int/search/en/detail.jsf;jsessionid=FCC09B14C354AEBCB207B511F1A03669.wapp2nB?docId=WO2019012149&tab=PCTDESCRIPTION&office=&prevFilter=&sortOption=Pub+Date+Desc&queryString=&recNum=8170&maxRec=73493415 https://patentscope.wipo.int/search/en/detail.jsf;jsessionid... and https://patents.google.com/patent/WO2018134265A1/en https://patents.google.com/patent/WO2018134265A1/en The language of patents is very very very difficult to read. (It's not your fauls, it's standard patent legalese.)Do you have a link to a research paper with similar content? <IIUC> This drug block the hydrolysis (destruction) of the ATP in mitochondria of the cancer cells. Usually the mitochondria produce ATP, but in this cancer cells the activity of the mitochondria is too low. The mitochondria also produce other useful molecules like NADPH while producing ATP. And if part of the APT is not destroyed, they can't produce the other useful molecules and the cell dies.</IIUC> How bad is that? I don't know if you can write a very simplified explanation without breaking the FDA rules or something, but add more information in the site. The graphic of the molecules are always nice. (And the 3D render is even nicer, in spite it's not so useful. Add both.)
- michaelforrest 8y agoCarboplatin is still used very prevalently for many cancers. It is now off patent, and old, but sitll in very common use in developed and developing countries. It is one of the most used cancer drugs. I've led with patents rather than papers because the latter can prevent the former ("prior art"). And no company will take a drug through clinical trials without a patent(s), and it is typically only companies that fund trials (espcially Phase III). So, publishing without patenting, if you actually have something promising, is near on a crime. It effectively renders it forever lost. This isn't actually as well known as it should be amongst researchers. Although most will never get to any point that this is of concern anyhow. RE: the crowdfunding page, thank you for your tips/advice on how to make it better, but today is the last day and as you can see....it is a bust. So, that is that.
- AnimalMuppet 8y agoWhen I read this, I can't tell the difference between "crackpot" and "maybe great idea". I guess I lean toward "maybe great idea", but the page gives off a definite "crackpot" vibe. Why? Too much self-promotion. No references. (Yeah, there are quotes from people. There are no papers cited that I saw. And one of the people says how great the author is, not how great the idea is.)
- michaelforrest 8y agoThere are references on the page. Follow the links! Two WO patents are cited (linked to), wherein a patent has to provide sufficient data, dislosure etc. to pass the patent examiner(s), who is scientifically trained, and ultimately it must be able to stand up to scrutiny in court, by very sophisticated (pharma compa[ny/ies]) assailants. It is a very expensive futility if done without underlying merit.
- AnimalMuppet 8y agoYes, I see the links to the patents. I was expecting links to something other than your own patents. (That's actually part of what gives it the "crackpot" vibe - linking to your own stuff.) Some links to info about F1F0 ATP hydrolysis that are not your own research would do a lot.
- michaelforrest 8y agoIt is original new research. Set in its context in the literature by the hundreds of references cited therein. Apologies for not just copying someone else's work. You would be well placed to actually read the patents/data/arguments/cited references. Especially before throwing around labels. At the end of the day, the drugs outperform in independent standardized tests at the National Cancer Institute. One is ready to enter Phase II clinical trials and these are soon to happen (for NSCLC). Yes there is much more work to do. And I am trying to do it. I am the first at this and the whole point of a patent(s) is to keep it like that (for a time): rendering a monopoly incentive that I can hopefully raise money against to move further foreward. Anyone that feels a tantrum coming on about patents, please look at how the crowdfunding campaign has bombed.